New guidelines for hypertrophic cardiomyopathy: the impact on prophylactic cardioverter-defibrillator implantation

被引:0
|
作者
Godinho, A. R. [1 ]
Vasconcelos, M. [1 ]
Rangel, I. [1 ]
Araujo, V. [1 ]
Frutuoso, C. [1 ]
Cardoso, J. S. C. [1 ]
Maciel, M. J. [1 ]
机构
[1] Univ Porto, Cardiol, P-4100 Oporto, Portugal
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P1460
引用
收藏
页码:307 / 307
页数:1
相关论文
共 50 条
  • [31] HYPERTROPHIC CARDIOMYOPATHY AND SYNCOPE: A NATIONAL OBSERVATION OF RATES OF IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR IMPLANTS
    Tandon, Varun
    Tandon, Aysha
    Balakumaran, Kathir
    Kumar, Manish
    CHEST, 2019, 156 (04) : 406A - 406A
  • [32] Is subcutaneous implantable cardioverter-defibrillator testing effective and safe for patients with hypertrophic cardiomyopathy?
    Qin, Fen
    Liu, Qiming
    Liu, Zhenjiang
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 246 : 54 - 54
  • [33] NONTHORACOTOMY CARDIOVERTER-DEFIBRILLATOR IMPLANTATION BY ELECTROPHYSIOLOGISTS
    MOLINA, JE
    CIRCULATION, 1995, 91 (01) : 252 - 253
  • [34] Impact of implantable cardioverter defibrillator therapy in patients with hypertrophic cardiomyopathy
    Dias, L. C.
    Saad, E. B.
    Slater, C.
    Inacio, L. A. O., Jr.
    Santos, G. V.
    Camanho, L. E. M.
    Mourilhe-Rocha, R.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 6 - 6
  • [35] An update on implantable cardioverter-defibrillator guidelines
    Epstein, AE
    CURRENT OPINION IN CARDIOLOGY, 2004, 19 (01) : 23 - 25
  • [36] Prophylactic implantable cardioverter-defibrillator in the very elderly
    Zakine, Cyril
    Garcia, Rodrigue
    Narayanan, Kumar
    Gandjbakhch, Estelle
    Algalarrondo, Vincent
    Lellouche, Nicolas
    Perier, Marie-Cecile
    Fauchier, Laurent
    Gras, Daniel
    Bordachar, Pierre
    Piot, Olivier
    Babuty, Dominique
    Sadoul, Nicolas
    Defaye, Pascal
    Deharo, Jean-Claude
    Klug, Didier
    Leclercq, Christophe
    Extramiana, Fabrice
    Boveda, Serge
    Marijon, Eloi
    EUROPACE, 2019, 21 (07): : 1063 - 1069
  • [37] VALUE OF PROPHYLACTIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR THERAPY
    KUCK, KH
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1994, 17 (03): : 514 - 516
  • [38] CONSISTENT SUBCUTANEOUS PREPECTORAL IMPLANTATION OF A NEW IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
    STANTON, MS
    HAYES, DL
    MUNGER, TM
    TRUSTY, JM
    ESPINOSA, RE
    SHEN, WK
    OSBORN, MJ
    PACKER, DL
    HAMMILL, SC
    MAYO CLINIC PROCEEDINGS, 1994, 69 (04) : 309 - 314
  • [39] New surgical approach to implantation of the subcutaneous implantable cardioverter-defibrillator
    Kennergren, Charles E. H.
    EUROPACE, 2017, 19 (12): : 1907 - 1908
  • [40] The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospital
    Anil-Martin Sinha
    Jens Bense
    Wolfgang Hohenforst-Schmidt
    Journal of Interventional Cardiac Electrophysiology, 2021, 62 : 401 - 407